January 20, 2026
August 9, 2018 @ 6:00 am CDT
- This event has passed.
FSU-Pensacola
Geriatrics Education Director Meeting
Speaker: John Agens, MD
Objectives: At the conclusion, the participant should be able to:
1) RECOGNIZE that primary care geriatrics students are responsible for determining if patients are on Beers list drugs; 2) DISCUSS empiric evidence for how frequently Beers criteria drugs are implicated in adverse drug events compared to other drug categories; 3) DISCUSS recent evidence based studies concerning anticholinergic medication and adverse effects on cognition; 4) DISCUSS how to engage a student in a discussion of shared decision making when thinking about initiating or stopping an anticholintergic drug for urge urinary incontinence: non-medication option, targets, and goals for each medication; 5) RECOGNIZE factors that promote shared decision making in deprescribing: Patient goals and physician targets for medication outcomes; 6) RECOGNIZE evidence that medication can be withdrawn safely and effectively; 7) DISCUSS the EMPOWER trial about how information given to patients triggered them to discuss reducing benzodiazepines with their providers, and reduce their medication using a step by step weaning program; 8) CONSIDER having a student look up useful tools https://www/deprescribingnetwork.ca/clinician-tools; 9) WORK through clinical cases of deprescribing of Beers list drugs and non-Beers list drugs; 10) REVIEW principles of a process of deprescribing that can be used as a framework for discussing with patients or students. Questions and answers will allow for audience participation.
1) RECOGNIZE that primary care geriatrics students are responsible for determining if patients are on Beers list drugs; 2) DISCUSS empiric evidence for how frequently Beers criteria drugs are implicated in adverse drug events compared to other drug categories; 3) DISCUSS recent evidence based studies concerning anticholinergic medication and adverse effects on cognition; 4) DISCUSS how to engage a student in a discussion of shared decision making when thinking about initiating or stopping an anticholintergic drug for urge urinary incontinence: non-medication option, targets, and goals for each medication; 5) RECOGNIZE factors that promote shared decision making in deprescribing: Patient goals and physician targets for medication outcomes; 6) RECOGNIZE evidence that medication can be withdrawn safely and effectively; 7) DISCUSS the EMPOWER trial about how information given to patients triggered them to discuss reducing benzodiazepines with their providers, and reduce their medication using a step by step weaning program; 8) CONSIDER having a student look up useful tools https://www/deprescribingnetwork.ca/clinician-tools; 9) WORK through clinical cases of deprescribing of Beers list drugs and non-Beers list drugs; 10) REVIEW principles of a process of deprescribing that can be used as a framework for discussing with patients or students. Questions and answers will allow for audience participation.